VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Wednesday, January 7, 2026

Stock Comparison

Boston Scientific Corporation vs Intertek Group plc

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Boston Scientific Corporation

BSX · New York Stock Exchange

Market cap (USD)$141.5B
Gross margin (TTM)65.1%
Operating margin (TTM)17.3%
Net margin (TTM)14.4%
SectorHealthcare
IndustryMedical - Devices
CountryUS
Data as of2026-01-04
Moat score
65/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Boston Scientific Corporation's moat claims, evidence, and risks.

View BSX analysis

Intertek Group plc

ITRK · London Stock Exchange

Market cap (USD)$7.1B
Gross margin (TTM)16.9%
Operating margin (TTM)16.9%
Net margin (TTM)9.9%
SectorIndustrials
IndustrySpecialty Business Services
CountryGB
Data as of2025-12-28
Moat score
64/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Intertek Group plc's moat claims, evidence, and risks.

View ITRK analysis

Comparison highlights

  • Moat score gap: Boston Scientific Corporation leads (65 / 100 vs 64 / 100 for Intertek Group plc).
  • Segment focus: Boston Scientific Corporation has 5 segments (49.8% in Cardiology); Intertek Group plc has 5 segments (28.3% in Consumer Products).
  • Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
  • Moat breadth: Boston Scientific Corporation has 6 moat types across 3 domains; Intertek Group plc has 6 across 3.

Primary market context

Boston Scientific Corporation

Cardiology

Market

Cardiology devices (interventional cardiology, structural heart, electrophysiology, cardiac rhythm management and remote monitoring)

Geography

Global

Customer

Hospitals/cath labs/EP labs and specialty clinics (cardiologists, electrophysiologists)

Role

Medical device OEM / implantables + procedure devices + service-enabled monitoring

Revenue share

49.8%

Intertek Group plc

Consumer Products

Market

Consumer products testing, inspection and certification (TIC/ATIC) services

Geography

Global

Customer

Brands, retailers, manufacturers

Role

Third-party conformity assessment and supply chain QA

Revenue share

28.3%

Side-by-side metrics

Boston Scientific Corporation
Intertek Group plc
Ticker / Exchange
BSX - New York Stock Exchange
ITRK - London Stock Exchange
Market cap (USD)
$141.5B
$7.1B
Gross margin (TTM)
65.1%
16.9%
Operating margin (TTM)
17.3%
16.9%
Net margin (TTM)
14.4%
9.9%
Sector
Healthcare
Industrials
Industry
Medical - Devices
Specialty Business Services
HQ country
US
GB
Primary segment
Cardiology
Consumer Products
Market structure
Oligopoly
Oligopoly
Market share
n/a
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Strong
Moat score
65 / 100
64 / 100
Moat domains
Demand, Legal, Supply
Supply, Demand, Legal
Last update
2026-01-04
2025-12-28

Moat coverage

Shared moat types

No overlap yet.

Boston Scientific Corporation strengths

Installed Base ConsumablesProcurement InertiaTraining Org Change CostsRegulated Standards PipeReputation ReviewsDistribution Control

Intertek Group plc strengths

Service Field NetworkData Workflow LockinBrand TrustCompliance AdvantageSuite BundlingDesign In Qualification

Segment mix

Boston Scientific Corporation segments

Full profile >

Endoscopy

Oligopoly

16%

Urology

Competitive

13.1%

Neuromodulation

Oligopoly

6.6%

Cardiology

Oligopoly

49.8%

Peripheral Interventions

Competitive

14.4%

Intertek Group plc segments

Full profile >

Consumer Products

Oligopoly

28.3%

Corporate Assurance

Competitive

14.6%

Health and Safety

Competitive

9.9%

Industry and Infrastructure

Competitive

24.9%

World of Energy

Oligopoly

22.3%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.